News | June 19, 2009

ASTRO to Honor Drs. Lawrence, Shipley with Gold Medal at November Meeting

Theodore Lawrence, M.D., Ph.D., FASTRO

William Shipley, M.D., FASTRO

June 19, 2009 - The American Society for Radiation Oncology (ASTRO) has selected Theodore Lawrence, M.D., Ph.D., FASTRO, and William Shipley, M.D., FASTRO, as its 2009 Gold Medal recipients, the highest honor that ASTRO bestows. Dr. Lawrence and Dr. Shipley will be presented with their awards at the Gold Medal Ceremony being held November 3, 2009, at 10:45 a.m. during ASTRO's 51st Annual Meeting in Chicago.

"Dr. Lawrence and Dr. Shipley have been outstanding contributors to the Society and to the field of radiation oncology as a whole," said Patricia Eifel, M.D., FASTRO, ASTRO chairman. "It is an honor and a personal pleasure for me to be able to present them with the Gold Medal this year in recognition of their distinguished careers and dedication to the specialty."

Dr. Lawrence is an Isadore Lampe professor of radiation oncology, chair of the Department of Radiation Oncology and a professor in the Department of Environmental Health, School of Public Health at the University of Michigan in Ann Arbor, Mich.

On a national level, Dr. Lawrence is the chair of the National Cancer Institute Board of Scientific Councilors and a member of the Institute of Medicine. He is also the editor of Translational Oncology, an editor of The Cancer Journal: Journal of the Principles and Practice of Oncology, and the associate editor of Seminars in Radiation Oncology. Dr. Lawrence is an ASTRO past president and former chairman of the Board, and a past member of the ASCO board of directors. He was also named by the ASTRO Board of Directors as one of the first general co-chairs of the of the Radiation Oncology Institute's Vision of Value fundraising campaign, which will raise money to help develop innovative ways of enhancing the profile of radiation oncology in the world cancer community and prepare the specialty for the future. His interests in the laboratory are focused on chemotherapeutic and molecularly targeted radiosensitizers, and his clinical research combines these laboratory studies with conformal radiation guided by metabolic and functional imaging for the treatment of patients with gastrointestinal and central nervous system malignancies.

Dr. Shipley is chair of the genitourinary oncology unit at Massachusetts General Hospital and the Andres Soriano professor of radiation oncology at Harvard Medical School, both in Boston.

Dr. Shipley is very active in medical societies both in the United States and abroad and has held committee appointments with several of these organizations, including the International Congress of Radiation Oncology, the International Society of Radiation Oncology, the National Bladder Cancer Group and the Radiation Therapy Oncology Group, among many others. Dr. Shipley has authored and co-authored over 160 medical reports, three text books on genitourinary oncology and more than 140 book chapters. He was named a fellow of the American College of Radiology in 1988 and an ASTRO Fellow in 2006.

Dr. Shipley has been actively involved with ASTRO's International Education Subcommittee since 2003, and in 2006, organized the first ASTRO-led international scientific and educational meeting in the Philippines, which was designed to help strengthen ASTRO's involvement in radiation oncology abroad and collaborate with related specialty societies in other countries. ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to improving patient care through education, clinical practice, advancement of science and advocacy.

For more information: www.astro.org

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more